comput
virtual
screen
strategi
use
earli
stage
drug
discoveri
pipelin
provid
power
tool
rapid
discoveri
small
biolog
activ
molecul
strategi
decreas
number
candid
compound
provid
good
start
point
chemic
synthesi
biolog
screen
therefor
mani
case
virtual
screen
use
prior
expens
experiment
highthroughput
screen
reason
sinc
term
comput
virtual
screen
came
late
consid
novel
essenti
technolog
drug
discoveri
ligandand
structurebas
virtual
screen
success
appli
drug
discoveri
program
variou
diseas
area
prospect
result
variou
protein
target
obtain
util
virtual
screen
identifi
compound
nucleic
acidbas
receptor
focu
much
attent
mani
comput
dock
program
automat
dock
small
molecul
bind
site
target
receptor
minimum
input
oper
develop
applic
proven
mcinn
addit
develop
variou
free
commerci
avail
databas
allow
easi
use
virtual
screen
year
mani
success
case
virtual
screen
variou
target
includ
protein
nucleotid
report
sever
major
review
paper
whitti
dock
process
concern
predict
ligand
conform
orient
within
target
bind
site
activ
site
kitchen
et
al
order
carri
dock
calcul
necessari
know
structur
target
natur
bind
site
structur
identi
fi
ed
xray
crystallographi
nmr
experi
download
protein
data
bank
pdb
berman
et
al
predict
homolog
model
use
variou
program
next
step
de
fi
ne
bind
site
known
inform
predict
input
prepar
chemic
compound
present
databas
dock
de
fi
ned
bind
site
select
target
receptor
two
purpos
dock
studi
one
predict
accur
ligand
bind
orient
refer
molecular
model
predict
activ
bind
af
fi
niti
refer
score
dock
result
evalu
ligand
bind
orient
visual
inspect
bind
af
fi
niti
use
score
function
score
function
design
predict
biolog
activ
bind
af
fi
niti
evalu
interact
ligand
receptor
halperin
et
al
among
variou
dock
program
tabl
wide
use
program
autodock
morri
et
al
huey
et
al
dock
ewe
et
al
flexx
kramer
et
al
stahl
gold
jone
et
al
glide
zhou
et
al
intern
coordin
mechan
icm
abagyan
totrov
sur
fl
exdock
jain
kellenberg
et
al
autodock
autom
fl
exibl
dock
program
design
predict
small
molecul
ligand
bind
receptor
structur
autodock
perform
empir
free
energi
forc
fi
eld
base
lamarckian
genet
algorithm
bring
speedi
predict
conform
calcul
free
energi
associ
morri
et
al
program
applic
xray
crystallographi
structurebas
drug
design
virtual
screen
proteinprotein
interact
studi
dock
introduc
kuntz
group
ucsf
use
rigid
bodi
dock
algorithm
fl
exibl
ligand
dock
algorithm
dock
ligand
neg
imag
bind
pocket
ewe
et
al
flexx
fulli
automat
comput
program
predict
proteinligand
interact
flexx
predict
lowest
energi
geometri
complex
ligand
protein
also
bind
af
fi
niti
use
empir
score
function
descript
wide
use
dock
program
includ
commerci
free
softwar
list
tabl
recent
year
number
identi
fi
ed
rna
sequenc
rapidli
increas
number
known
structur
kept
pace
reason
larg
gap
number
known
rna
sequenc
structur
exampl
trna
one
structur
well
character
rna
character
sequenc
report
rfam
gardner
et
al
mani
clinic
antibiot
includ
macrolid
aminoglycosid
other
target
bacteri
ribosom
rna
rrna
reveal
rna
import
target
drug
develop
knowl
et
al
hermann
appear
drug
resist
critic
problem
treat
bacteri
neu
viral
infect
perrin
telenti
rna
contain
highli
conserv
structur
function
motif
may
serv
drug
target
develop
resist
drug
target
rna
slower
drug
target
protein
gallego
varani
contrast
dna
mostli
doublestrand
helix
structur
rna
gener
singlestrand
fold
complex
structur
provid
uniqu
pocket
small
molecul
folopp
et
al
thu
make
rna
attract
drug
target
spite
advantag
rna
focu
structurebas
drug
design
due
lack
inform
rna
structur
also
due
sequencespeci
fi
c
uniqu
featur
bind
pocket
rna
bind
pocket
protein
usual
lie
deep
intern
region
separ
solvent
rna
target
bind
pocket
larg
fl
locat
along
surfac
rel
expos
solvent
therefor
use
dock
algorithm
discov
rnabind
drug
physicochem
properti
rna
conform
fl
exibl
high
neg
charg
solvat
taken
account
accur
protein
despit
differ
protein
rna
target
classic
proteinligand
dock
program
sometim
success
perform
rnatarget
virtual
screen
exampl
kuntz
fi
rst
report
success
virtual
screen
use
dock
program
identifi
small
molecul
avail
chemic
directori
acd
target
rna
doubl
helix
chen
et
al
follow
fi
rst
studi
mani
research
group
report
success
studi
virtual
screen
target
rna
proteinbas
dock
method
filikov
et
al
lind
et
al
kang
et
al
park
et
al
park
et
al
meanwhil
sinc
avail
dock
method
develop
protein
target
complianc
rna
target
evalu
extens
recent
li
et
al
demonstr
two
widelyus
protein
dock
program
gold
glide
appropri
structurebas
drug
design
virtual
screen
rna
target
deter
varani
li
et
al
sever
modi
fi
ed
algorithm
establish
rnatarget
virtual
screen
exampl
morley
afshar
establish
empir
score
function
appropri
describ
steric
polar
charg
interact
rnaligand
complex
morley
afshar
score
function
implant
ribodock
program
valid
dock
screen
larges
chemic
databas
virtual
screen
program
success
identi
fi
ed
novel
ligand
bacteri
ribosom
asit
folopp
et
al
moitessi
et
al
appli
uniqu
method
autodock
dock
process
take
account
inher
rna
fl
exibl
key
water
molecul
modi
fi
ed
dock
tool
valid
moitessi
et
al
kuntz
et
al
studi
experiment
rnaligand
complex
pdb
redock
use
dock
program
result
dock
conform
rescor
amber
gener
bornsolventaccess
surfac
area
gbsa
poissonblotzmannsa
pbsa
score
function
combin
explicit
water
molecul
sodium
counterion
success
rate
reproduc
experiment
bind
mode
signi
fi
cantli
improv
use
amber
gbsa
pbsa
lang
et
al
small
molecul
induc
rna
conform
chang
bind
structur
preexist
dynam
ensembl
puglisi
et
al
zhang
et
al
frank
et
al
cruz
westhof
full
gohlk
larg
conform
chang
rna
receptor
bind
small
molecul
virtual
screen
must
account
howev
current
protocol
consid
point
limit
rang
target
structur
discoveri
small
molecul
guilbert
jame
therefor
develop
fl
exibl
dock
program
call
mordor
support
fl
exibl
ligand
limit
fl
exibl
rna
inducedfi
bind
mordor
perform
well
test
set
rnaligand
complex
retriev
experiment
pose
within
success
rate
also
discov
ligand
novel
target
human
telomeras
rna
pinto
et
al
compar
practic
dock
mordor
dock
screen
time
faster
mordor
mordor
perform
better
ligand
larg
number
rotat
bond
lang
et
al
recent
alhashimi
group
report
new
strategi
virtual
screen
target
rna
dynam
ensembl
construct
combin
nmr
spectroscopi
comput
molecular
dynam
md
stelzer
et
al
strategi
take
account
larg
degre
rna
conform
adapt
virtual
screen
approach
appli
search
small
molecul
tar
transactiv
respons
element
rna
vide
infra
one
best
character
rnabas
regulatori
machineri
interact
tar
tat
protein
focus
upon
target
inhibit
replic
yang
ligand
inhibit
tartat
interact
develop
antiaid
drug
variou
molecul
tar
rna
inhibit
tat
bind
identi
fi
ed
mani
molecul
discov
virtual
screen
chemic
librari
earlier
studi
jame
use
automat
dock
method
dock
icm
employ
fl
exibl
dock
mont
carlo
simul
optim
score
function
identifi
phenothiazin
compound
acd
tar
rna
ligand
filikov
et
al
lind
et
al
circumv
limit
incorpor
rna
fl
exibl
structurebas
virtual
screen
fi
nd
novel
scaffold
tartat
inhibitor
ligandbas
virtual
screen
conduct
squid
fuzzi
pharmacophor
search
method
success
identi
fi
ed
novel
heterocycl
compound
order
magnitud
improv
activ
compar
known
phenothiazin
compound
renner
et
al
alhashimi
group
develop
outstand
technolog
rnatarget
virtual
screen
intens
gener
ensembl
tar
rna
conform
robust
redock
valid
test
strategi
effect
appli
virtual
screen
rel
smallsiz
chemic
librari
contain
compound
identi
fi
ed
netilmicin
select
tar
rna
binder
inhibit
replic
vivo
stelzer
et
al
detail
studi
describ
test
accuraci
dock
total
small
moleculebound
rna
structur
download
pdb
assess
dock
perform
dock
perform
carri
use
icm
dock
program
abagyan
totrov
result
evalu
icm
score
rmsd
nativ
ligand
extract
rna
structur
predict
orient
dock
bind
energi
base
icm
score
predict
high
accuraci
r
half
case
predict
conform
match
xray
nmr
structur
within
rmsd
decid
suitabl
rna
ensembl
accuraci
dock
two
set
rna
ensembl
tar
compar
one
ensembl
name
tar
nmrmd
consist
conform
gener
sa
select
selectandsampl
strategi
frank
et
al
construct
tar
nmrmd
tar
structur
pdb
id
aboulela
et
al
download
molecular
dynam
simul
perform
measur
nmr
residu
dipolar
coupl
rdc
elong
rna
rna
ensembl
name
tar
md
consist
randomli
select
snapshot
md
simul
apotar
backbon
rmsd
rang
xray
structur
pdb
id
ippolito
steitz
nmr
structur
pdb
id
aboulela
et
al
apotar
download
pdb
test
set
ligand
librari
contain
known
ligand
tar
rna
obtain
publish
literatur
test
accuraci
rna
ensembl
virtual
screen
test
set
ligand
target
rna
ensembl
tar
nmrmd
tar
md
conduct
respect
virtual
screen
conduct
use
icm
bind
pocket
predict
icm
pocketfind
modul
base
calcul
surfac
area
volum
caviti
receptor
surfac
result
suggest
tar
nmrmd
improv
accuraci
dock
compar
tar
md
result
tar
nmrmd
chosen
virtual
screen
identifi
small
molecul
tartat
inhibitor
chemic
databas
consist
compound
obtain
center
chemic
genom
univers
michigan
compound
author
inhous
librari
base
icm
score
top
commerci
avail
hit
compound
select
bind
activ
test
fl
uorescencebas
assay
identi
fi
ed
six
small
molecul
bound
tar
high
af
fi
niti
k
nm
inhibit
tar
interact
tat
ribosom
frameshift
fs
essenti
event
translat
synthesi
two
protein
encod
overlap
read
frame
singl
mrna
dinman
berri
mani
rna
virus
retrovirus
coronavirus
yeast
plant
viru
even
bacteria
jack
varmu
brierley
et
al
chamorro
et
al
tzeng
et
al
ten
dam
et
al
kang
tinoco
jacob
et
al
two
ci
act
element
requir
regul
fs
one
slipperi
sequenc
ribosomeassoci
trna
slip
rna
secondari
structur
hairpin
pseudoknot
promot
ribosom
paus
thermodynam
kinet
control
rna
secondari
structur
fold
may
import
regul
ef
fi
cienci
fs
human
immunod
fi
cienci
viru
type
util
fs
regul
express
ratio
gag
gagpol
critic
product
infecti
virion
particl
paulu
et
al
rna
stemloop
sequenc
involv
fs
highli
conserv
main
subtyp
gareiss
miller
mutat
sequenc
reduc
fs
decreas
viral
infect
replic
baril
et
al
dulud
et
al
sever
acut
respiratori
syndrom
coronaviru
sarscov
replicas
gene
mainli
encod
two
larg
replic
polyprotein
express
two
partial
overlap
open
read
frame
orf
orf
orf
independ
translat
initi
site
polyprotein
encod
orf
translat
fuse
protein
form
orf
fs
includ
rnadepend
rna
polymeras
rdrp
replic
compon
import
protein
viral
replic
fs
essenti
synthesi
enzymat
protein
stabil
rna
pseudoknot
induc
fs
sarscov
sarspseudoknot
also
dramat
effect
fs
ef
fi
cienci
therefor
rna
secondari
structur
fs
site
emerg
attract
target
drug
develop
baranov
et
al
plant
et
al
su
et
al
park
fi
rst
conduct
virtual
screen
rna
pseudoknot
fs
site
discov
ligand
chang
fs
ef
fi
cienci
park
et
al
pilot
studi
use
fs
system
contain
biotin
aptam
rna
pseudoknot
rna
secondari
structur
element
biotin
rna
aptam
ligandbound
rna
pseudoknot
structur
pdb
id
determin
xcrystallographi
nix
et
al
park
et
al
use
convent
pharmacophor
search
program
uniti
martin
primari
databas
fi
ltere
flexx
dock
program
fi
nal
dock
screen
rna
fl
exibl
consid
ligand
fl
exibl
given
flexx
run
compound
chemic
db
obtain
hit
increas
fs
compound
show
highest
activ
vitro
transcript
translat
coupl
assay
fig
flexxdock
pose
shown
fig
dock
mode
similar
biotin
howev
form
stronger
interact
receptor
rna
fig
compound
form
hydrogen
bond
oxygen
uracil
ring
one
critic
residu
interact
biotin
xray
structur
addit
hydrogen
bond
ribos
atom
fig
interact
may
alter
stabil
rna
pseudoknot
increas
stall
time
ribosom
slipperi
site
thu
increas
rate
fs
base
success
result
park
appli
virtual
screen
strategi
discov
ligand
sarspseudoknot
even
though
structur
complet
determin
known
sarspseudoknot
uniqu
loop
structur
built
model
use
rna
pseudoknot
predict
program
pseudoview
sybyl
molecular
model
softwar
threedimension
structur
model
sarspseudoknot
use
studi
optim
molecular
dynam
simul
use
amber
program
brown
ribbon
render
phosphat
backbon
rna
pseudoknot
optim
rna
structur
amber
molecular
dynam
simul
case
et
al
fig
use
dock
program
fl
exibl
dock
commerciallyavail
chemic
db
leadquest
conduct
chemic
db
previous
use
screen
biotin
aptam
rna
pseudoknot
total
compound
inhibit
fs
three
structur
analog
compound
fig
reduc
fs
select
compound
activ
decreas
fs
ef
fi
cienci
hek
cell
inhibit
fs
concentrationdepend
manner
ic
valu
approxim
park
et
al
dock
model
complex
sarspseudoknot
shown
fig
reveal
interact
variou
residu
includ
key
residu
maintain
frameshift
ef
fi
cienci
hydrogen
bond
compound
interact
carbonyl
oxygen
atom
uracil
base
hydrogen
bond
nitrogen
atom
thiazol
ring
form
hydrogen
bond
oh
group
ribos
hydrogen
bond
thiazol
moieti
receptor
pseudoknot
identi
fi
ed
one
key
intermolecular
interact
riboswitch
highli
organ
domain
within
utr
mrna
undergo
altern
conform
switch
riboswitch
consist
two
domain
aptam
domain
bind
site
effector
metabolit
express
platform
prompt
chang
gene
express
upon
metabolit
bind
one
riboswitch
conform
stabil
capabl
control
express
et
al
mironov
et
al
gilbert
batey
bacteria
winkler
et
al
mandal
et
al
well
plant
fungi
sudarsan
et
al
bocobza
aharoni
therefor
aptam
domain
essenti
element
gene
regul
riboswitch
origin
discov
antibiot
target
blount
breaker
lee
et
al
kim
et
al
also
potenti
develop
design
riboswitch
genet
studi
suess
weigand
class
riboswitch
report
larg
number
probabl
new
class
may
await
discoveri
among
guanin
riboswitch
one
valid
target
develop
new
antibacteri
drug
xray
crystal
structur
riboswitch
determin
thu
structurebas
drug
design
approach
appli
target
serganov
daldrop
et
al
tri
virtual
screen
discov
novel
ligand
target
purin
riboswitch
use
program
minor
modi
fi
cation
score
function
daldrop
et
al
bacillu
subtili
xptpbux
guanin
riboswitch
carri
mutat
call
gra
pdb
id
gilbert
et
al
complex
use
target
receptor
dock
dock
virtual
screen
studi
carri
use
slightli
modi
fi
ed
version
program
incorpor
rnaspeci
fi
c
paramet
calcul
van
der
waal
electrostat
energi
group
fi
rst
test
whether
nativ
ligand
correctli
reproduc
term
bind
geometri
selfdock
rmsd
nativ
ligand
dock
result
measur
rmsd
less
show
dock
model
close
nativ
secondli
accuraci
predict
test
dock
known
ligand
decoy
test
set
consist
eight
known
ligand
bind
af
fi
niti
rang
decoy
bind
detect
except
guanin
test
solubl
limit
compound
test
set
dock
activ
site
result
analyz
sort
dock
score
seven
eight
topscor
compound
true
ligand
eight
compound
lowest
dock
energi
score
decoy
use
inhous
databas
includ
commerci
avail
uniqu
compound
evalu
accuraci
bind
predict
compound
databas
dock
activ
site
order
dock
score
accord
list
true
posit
rate
fraction
known
compound
ligand
decoy
plot
fals
posit
fraction
unassign
databas
compound
get
receiv
oper
characterist
roc
curv
accuraci
calcul
measur
area
curv
auc
roc
curv
valu
auc
valu
ligand
decoy
suggest
known
ligand
perfectli
predict
virtual
screen
decoy
also
enrich
compar
random
auc
result
fi
compound
select
examin
bind
af
fi
niti
mode
three
compound
fi
analog
known
ligand
two
compound
novel
scaffold
determin
bind
af
fi
niti
fl
uoresc
assay
isotherm
titrat
calorimetri
itc
use
four
fi
chosen
compound
bound
gra
af
fi
niti
micromolar
rang
rapidli
increas
number
rna
crystal
structur
pdb
biolog
function
studi
varieti
rna
structur
provid
basi
structurebas
virtual
screen
target
rna
due
sever
featur
rna
conform
fl
exibl
high
neg
charg
solvat
differ
protein
research
observ
convent
proteinligand
dock
program
limit
accur
predict
rnaligand
interact
studi
activ
molecul
fortuit
obtain
proteintarget
dock
program
howev
continu
progress
made
develop
dock
algorithm
score
function
optim
rna
receptor
make
variou
rna
target
amen
structurebas
drug
design
exampl
consider
receptor
fl
exibl
import
rnabas
receptor
also
critic
issu
protein
receptor
long
time
massiv
effort
made
incorpor
protein
fl
exibl
dock
process
exponenti
fl
ate
potenti
search
space
becam
impract
alhashimi
approach
use
rna
dynam
ensembl
stelzer
et
al
practic
appli
rna
target
rna
receptor
usual
smaller
protein
receptor
size
process
gener
rna
ensembl
extrem
comput
expens
structureor
ligandbas
virtual
screen
identi
fi
ed
plethora
rna
bind
ligand
inhous
commerci
avail
chemic
databas
origin
design
prepar
protein
target
actual
commerci
chemic
databas
possess
compound
satisfi
lipinski
rule
fi
lipinski
et
al
compar
activ
small
molecul
rna
binder
identi
fi
ed
virtual
screen
realiz
hit
nanomolar
activ
rare
overal
activ
high
micromolar
rang
result
probabl
caus
limit
current
avail
chemic
databas
proteinfriendli
dock
algorithm
proteintarget
virtual
screen
chemic
databas
mani
hit
nanomolar
submicromolar
activ
identi
fi
ed
thu
anoth
possibl
way
improv
hit
rate
rnatarget
virtual
screen
prepar
rnafocus
chemic
databas
consid
physicochem
properti
rna
binder
modi
fi
ed
lipinski
rule
fi
need
appli
databas
fi
ltere
virtual
screen
aboulela
